The cyclic pentapeptide d-arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice

Endocrinology

Volumn 152, Issue 2, 2011, Pages 536-544

  Kim, Jeong Mo ^a,b   Lee, Yong Ho ^a   Ku, Cheol Ryong ^a   Lee, Eun Jig ^a,b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; D ARG3FC131 PEPTIDE; GROWTH HORMONE; UNCLASSIFIED DRUG;

ACROMEGALY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN GH3; CONTROLLED STUDY; HORMONE SYNTHESIS; HYPOPHYSIS TUMOR; IMMUNE DEFICIENCY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; FLOW CYTOMETRY; GENETIC VECTORS; GROWTH HORMONE; IN SITU NICK-END LABELING; MALE; MICE; MICE, NUDE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PITUITARY NEOPLASMS; RATS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATOTROPHS;

EID: 79951664559     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0642     Document Type: Article

References (39)

1. Melmed S 2006 Medical progress: Acromegaly. N Engl J Med 355:2558-2573
2. Colao A, Ferone D, Marzullo P, Lombardi G 2004 Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152 (Pubitemid 38269977)
3. Burt MG, Ho KK 2006 Newer options in the management of acromegaly. Intern Med J 36:437-444 (Pubitemid 43876238)
4. Freda PU 2002 Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 87:3013-3018 (Pubitemid 34816336)
5. Feenstra J, de Herder WW, ten Have SM, van den Beld AW, Feelders RA, Janssen JA, van der Lely AJ 2005 Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly. Lancet 365:1644-1646 (Pubitemid 40693415)
6. Trainer PJ, Ezzat S, D'Souza GA, Layton G, Strasburger CJ 2009 A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly. Clin Endocrinol (Oxf) 71:549-557
7. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR 2001 Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61:4961-4965
8. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B 1996 The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cellline-adapted HIV-1. Nature 382:833-835 (Pubitemid 26299571)
9. Hesselgesser J, Liang M, Hoxie J, Greenberg M, Brass LF, Orsini MJ, Taub D, Horuk R 1998 Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J Immunol 160:877-883 (Pubitemid 28049330)
10. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE 2000 Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 165:6590-6598
11. Lataillade JJ, Clay D, Bourin P, Hérodin F, Dupuy C, Jasmin C, Le Bousse-Kerdilès MC 2002 Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99:1117-1129
12. 125I] stromal cell-derived factor-1α binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J Neuroimmunol 110:151-160
13. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T 1993 Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261:600-603 (Pubitemid 23278369)
14. Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F 2008 Involvement of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer 122:91-99 (Pubitemid 350209982)
15. Zheng H, Fu G, Dai T, Huang H 2007 Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1α/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50:274-280 (Pubitemid 47428975)
16. Barbieri F, Bajetto A, Stumm R, Pattarozzi A, Porcile C, Zona G, Dorcaratto A, Ravetti JL, Minuto F, Spaziante R, Schettini G, Ferone D, Florio T 2008 Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 14:5022-5032
17. Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I 2006 Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181-2187
18. Bajetto A, Barbieri F, Dorcaratto A, Barbero S, Daga A, Porcile C, Ravetti JL, Zona G, Spaziante R, Corte G, Schettini G, Florio T 2006 Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 49:423-432 (Pubitemid 44189638)
19. Florio T, Casagrande S, Diana F, Bajetto A, Porcile C, Zona G, Thellung S, Arena S, Pattarozzi A, Corsaro A, Spaziante R, Robello M, Schettini G 2006 Chemokine stromal cell-derived factor 1α induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals. Mol Pharmacol 69:539-546 (Pubitemid 43121951)
20. Banisadr G, Skrzydelski D, Kitabgi P, Rostène W, Parsadaniantz SM 2003 Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci 18:1593-1606
21. Callewaere C, Fernette B, Raison D, Mechighel P, Burlet A, Calas A, Kitabgi P, Parsadaniantz SM, Rostène W 2008 Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats. Endocrinology 149:310-319
22. Lee Y, Kim JM, Lee EJ 2008 Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation. J Endocrinol 199:191-199
23. Lee YH, Noh TW, Lee MK, Jameson JL, Lee EJ 2010 Absence of activating mutations of CXCR4 in pituitary tumours. Clin Endocrinol (Oxf) 72:209-213
24. Barbieri F, Bajetto A, Porcile C, Pattarozzi A, Schettini G, Florio T 2007 Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J Mol Endocrinol 38:383-389 (Pubitemid 46723254)
25. Tamamura H, Omagari A, Oishi S, Kanamoto T, Yamamoto N, Peiper SC, Nakashima H, Otaka A, Fujii N 2000 Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes. Bioorg Med Chem Lett 10:2633-2637
26. Tamamura H, Sugioka M, Odagaki Y, Omagari A, Kan Y, Oishi S, Nakashima H, Yamamoto N, Peiper SC, Hamanaka N, Otaka A, Fujii N 2001 Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity. Bioorg Med Chem Lett 11:359-362 (Pubitemid 32115846)
27. Tamamura H, Hiramatsu K, Mizumoto M, Ueda S, Kusano S, Terakubo S, Akamatsu M, Yamamoto N, Trent JO, Wang Z, Peiper SC, Nakashima H, Otaka A, Fujii N 2003 Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists. Org Biomol Chem 1:3663-3669
28. Fujii N, Oishi S, Hiramatsu K, Araki T, Ueda S, Tamamura H, Otaka A, Kusano S, Terakubo S, Nakashima H, Broach JA, Trent JO, Wang ZX, Peiper SC 2003 Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries. Angew Chem Int Ed Engl 42:3251-3253 (Pubitemid 36917168)
29. Lee EJ, Duan WR, Kotlar T, Jameson JL 2001 Restoration of growth hormone-releasing hormone (GHRH) responsiveness in pituitary GH3 cells by adenovirus-directed expression of the human GHRH receptor. Endocrinology 142:414-420 (Pubitemid 32183703)
30. Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, Stalla GK, Schilling T, Arzt E, Perone MJ, Renner U 2009 Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer 16:1339-1350
31. Lee EJ, Anderson LM, Thimmapaya B, Jameson JL 1999 Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors. J Clin Endocrinol Metab 84:786-794 (Pubitemid 29075722)
32. Cheung NW, Boyages SC 1995 Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block. Endocrinology 136:4174-4181
33. Ishikawa T, Lee EJ, Jameson JL 2004 Nonhomologous end-joining ligation transfers DNA regulatory elements between cointroduced plasmids. Mol Cell Biol 24:8323-8331 (Pubitemid 39245055)
34. Lee EJ, Duan WR, Jakacka M, Gehm BD, Jameson JL 2001 Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 142:3756-3763 (Pubitemid 32802646)
35. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA 2003 A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100:13513-13518 (Pubitemid 37444773)
36. Burger JA, Kipps TJ 2006 CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761-1767 (Pubitemid 43289351)
37. Petit I, Jin D, Rafii S 2007 The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28:299-307 (Pubitemid 46963141)
38. Zheng H, Dai T, Zhou B, Zhu J, Huang H, Wang M, Fu G 2008 SDF-1α/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis 201:36-42
39. Broxmeyer HE, Cooper S, Kohli L, Hangoc G, Lee Y, Mantel C, Clapp DW, Kim CH 2003 Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol 170:421-429 (Pubitemid 36026167)